Genetic Modification of Limbs Using Machine Perfusion.

Genetic engineering is a promising tool to repair genetic disorders, improve graft function, or reduce immune responses toward allografts. organ perfusion systems have the potential to mitigate ischemic-reperfusion injury, prolong preservation time, or even rescue organ function. We aim at combining both technologies to develop a modular platform allowing the genetic modification of vascularized composite (VC) allografts.

Genetic Engineering of the Kidney to Permanently Silence MHC Transcripts During Organ Perfusion.

Organ gene therapy represents a promising tool to correct diseases or improve graft survival after transplantation. Polymorphic variation of the major histocompatibility complex (MHC) antigens remains a major obstacle to long-term graft survival after transplantation. Previously, we demonstrated that MHC-silenced cells are protected against allogeneic immune responses.